Genetic Signatures reported AUD227.14M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Medical Developments International AUD 112.66M 2.35M Dec/2025
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
Pacific Edge NZD 1.02B 210.22M Dec/2025
Paradigm Biopharmaceuticals AUD 428.52M 39.09M Dec/2025
Starpharma Holdings AUD 419.92M 179.17M Dec/2025
Telix Pharmaceuticals AUD 338.78M 379K Dec/2025